Inside The Push For Over-The-Counter Naloxone

The FDA has recently taken an unprecedented step to kickstart the development of over-the-counter naloxone products.  Last week the FDA took an unprecedented step to make the anti-overdose drug naloxone directly available to opioid users. Currently, naloxone requires a prescription. But in an effort to make approval for non-prescription versions of the drug easier for… Continue reading Inside The Push For Over-The-Counter Naloxone

Naloxone Price Spiked 600% During Opioid Crisis By Drug Maker

One drug manufacturer reportedly increased the price of its naloxone drug Evzio from $575 per dose to $4,100 per dose. Naloxone, the opioid overdose reversal drug, has been heralded as a lifesaving intervention credited with helping stem the death toll of the opioid epidemic. However, one drug manufacturer reportedly saw the demand for the drug… Continue reading Naloxone Price Spiked 600% During Opioid Crisis By Drug Maker

Will Naloxone Be Co-Prescribed With Opioid Painkillers In The Future?

While some states already require the co-prescription, the FDA is considering making it a requirement across the US. In an effort to decrease overdose deaths, doctors could soon be required to prescribe an opioid overdose antidote any time they prescribe prescription painkillers, according to Food and Drug Administration (FDA) Commissioner Scott Gottlieb.   The idea… Continue reading Will Naloxone Be Co-Prescribed With Opioid Painkillers In The Future?

Opioid Antidote Naloxone Recalled By Manufacturer

A batch of units sold between February 2017 and February 2018 are being recalled by the manufacturer.  The life-saving opioid overdose antidote naloxone has been recalled by its manufacturer, the Food and Drug Administration (FDA) announced. Drug company Hospira and its parent company Pfizer issued the recall on Monday, CNN reported, after discovering “loose particulate matter… Continue reading Opioid Antidote Naloxone Recalled By Manufacturer

Exit mobile version